Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.
Women like Dina Pattelli who have lost dramatic weight thanks to buzzy meds like Ozempic are now struggling to dress their new bodies. Tamara Beckwith/N.Y.Post Dina Pattelli can’t weight to wow ...
Forty years after the Hatch-Waxman Act revolutionized the prescription drug ... average co-pay for a generic drug was $6.16 versus $56.12 for a brand-name drug in 2022, a white paper by the ...